Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2015 | A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results. | Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil | J. Clin. Oncol. | | | |
2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | CHING-YAO YANG ; Liao, Wei-Yu; Ho, Chao-Chi; Chen, Kuan-Yu; Tsai, Tzu-Hsiu; Hsu, Chia-Lin; Liu, Yi-Nan; Su, Kang-Yi; Chang, Yih-Leong; Wu, Chen-Tu; Liao, Bin-Chi; Hsu, Chia-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen | The oncologist | 8 | 8 | |
2014 | Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung Cancer | Lee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-Hsin; 楊泮池 | J. Thorac. Oncol. | | | |
2014 | Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung Cancer | Lee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-Hsin | J. Thorac. Oncol. | | | |
2016 | Comparison of skin toxic effects associated with gefitinib, erlotinib, or afatinib treatment for non-small cell lung cancer | Yi-Shuan Sheen; Chen, Kai-Lung; CHIA-YU CHU; Lin, Chia-Chi; Cho, Yung-Tsu; Yang, Che-Wen; Tsai, Hsiao-En; Chu, Chia-Yu | JAMA Dermatology | 17 | 18 | |
2006 | Differential Expression of Molecular Markers in Arsenic and Non-arsenic-related Urothelial Cancer | Hour, Tzyh-Chyuan; Pu, Yeong-Shiau; Lin, Chia-Chi; Huang, Shi-Wei; Chen, Jun; Chiu, Allen W.; Chen, Chien-Jen; Huang, Chao-Yuan | Anticancer Research | | | |
2008 | Down-Regulated Expression of Rhoa in Human Conventional Renal Cell Carcinoma | PU, YEONG-SHIAU; WANG, CHUANG-WEI; LIU, GUANG-YAW; KUO, YI-ZIH; HUANG, CHAO-YUAN; SHUN, CHIA-TUNG; LIN, CHIA-CHI; WU, WEN-JENG; HOUR, TZYH-CHYUAN | ANTICANCER RESEARCH | | | |
2008 | Down-Regulated Expression of RhoA in Human Conventional Renal Cell Carcinoma | Pu, Yeong-Shiau; Wang, Chuang-Wei; Liu, Guang-Yaw; Kuo, Yi-Zih; Huang, Chao-Yuan; Kang, Wang-Yi; Shun, Chia-Tung; Lin, Chia-Chi; Wu, Wen-Jeng; Hour, Tzyh-Chyuan | ANTICANCER RESEARCH | | | |
2013 | EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer | Kao, Hsiang-Fong; Lin, Chia-Chi; Yang, James Chih-Hsin | Future Oncology | 7 | 6 | |
2021 | Endoscopic ultrasound ablation in a patient with multiple metastatic pancreatic tumors from adrenocorticotropic hormone-producing thymic neuroendocrine neoplasm | Chang, Ling-Kai; Chen, Kuan-Chih; Cheng, Mei-Fang; Lin, Chia-Chi; Wang, Hsiu-Po; Sung, Chia-Tung; Chen, Jou-Ho; Yen, Ruoh-Fang; Hsu, Chia-Lin; SHYANG-RONG SHIH | Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society | 1 | 1 | |
2021 | Endoscopic ultrasound ablation in a patient with multiple metastatic pancreatic tumors from adrenocorticotropic hormone-producing thymic neuroendocrine neoplasm | Chang, Ling-Kai; Chen, Kuan-Chih; Cheng, Mei-Fang; Lin, Chia-Chi; Wang, Hsiu-Po; Sung, Chia-Tung; Chen, Jou-Ho; Yen, Ruoh-Fang; CHIA-LIN HSU ; Shih, Shyang-Rong | Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society | | 1 | |
2006 | Epidermal Growth Factor Receptor Inhibitor (Pd168393) Potentiates Cytotoxic Effects of Paclitaxel against Androgen-Independent Prostate Cancer Cells | PU, YEONG-SHIAU; HSIEH, MIN-WEI; WANG, CHUANG-WEI; LIU, GUANG-YAW; HUANG, CHAO-YUAN; LIN, CHIA-CHI; GUAN, JING-YI; LIN, SHINNE- REN; HOUR, TZYH-CHYUAN; 蒲永孝; 謝旻娓; 王壯維; 劉光耀; 黃昭淵; 林家齊; 官靜儀; 林信仁; 侯自銓 | BIOCHEMICAL PHARMACOLOGY | | | |
2006 | Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells | Pu, Yeong-Shiau; Hsieh, Min-Wei; Wang, Chuang-Wei; Liu, Guang-Yaw; Huang, Chao-Yuan; Lin, Chia-Chi; Guan, Jing-Yi; Lin, Shinne-Ren; Hour, Tzyh-Chyuan | Biochemical Pharmacology | | | |
2015 | Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis. | Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
2015 | Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis. | Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin | J. Clin. Oncol. | | | |
2021 | Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy | SHYANG-RONG SHIH ; Liao, Shu-Lang; Shih, Chih-Wei; Wei, Yi-Hsuan; Lu, Ting-Xuan; Chou, Chien-Hsiang; Yen, Er-Yen; Chang, Yi-Cheng; Lin, Chia-Chi; Chi, Yu-Chiao; Yang, Wei-Shiung; Tsai, Feng-Chiao | Ocular immunology and inflammation | 0 | 1 | |
2022 | Immunotherapy in anaplastic thyroid cancer: Case series | Shih, Shyang-Rong; Chen, Kuan-Hua; Lin, Kuan-Yu; Yang, Pan-Chyr; KUEN-YUAN CHEN ; Wang, Chun-Wei; Chen, Chun-Nan; Lin, Chih-Feng; Lin, Chia-Chi | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
2022 | Immunotherapy in anaplastic thyroid cancer: Case series | Shih, Shyang-Rong; Chen, Kuan-Hua; Lin, Kuan-Yu; PAN-CHYR YANG ; Chen, Kuen-Yuan; Wang, Chun-Wei; Chen, Chun-Nan; Lin, Chih-Feng; Lin, Chia-Chi | Journal of the Formosan Medical Association = Taiwan yi zhi | | 0 | |
2020 | An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor-Refractory ALK-Positive or ROS1-Positive NSCLC | Zhu, Viola W; YEN-TING LIN ; Kim, Dong-Wan; Loong, Herbert H; Nagasaka, Misako; To, Hao; Ang, Yvonne Li-En; Ock, Chan-Young; Tchekmedyian, Nishan; Ou, Sai-Hong Ignatius; Syn, Nicholas L; Reungwetwattana, Thanyanan; Lin, Chia-Chi; Soo, Ross A | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 24 | 18 | |
2015 | Ipilimumab in treating Asian patient with advanced melanoma: The preliminary report of Taiwan ipilimumab extended access program group | Wu, Chun-Feng; Huang, Wen Kuan; Liu, Jun-Huang; Lin, Chen-Yuan; Liu, Ta-Chih; Lin, Chia-Chi; Su, Wu-Chou; Yeh, Yumin; Cheng, Shih-Tsung; Lin, Sheng-Fung; Hong, Ruey-Long; Chang, John W. C. | J. Clin. Oncol. | | | |